Back to Search
MARTHA WADLEIGH, MD
MD
Medical Oncology Physician
NPI: 1972578185IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
209746(MA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 1998
Research & Publications (20)
The role of myeloid growth factors in acute leukemia.
PMID 19176208·J Natl Compr Canc Netw·2009
6-review
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies.
PMID 15358622·Blood·2005
6-review
Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.
PMID 14564177·Curr Opin Hematol·2003
6-review
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation.
PMID 12738663·Blood·2003
8-other
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.
PMID 19420352·Blood·2009
8-other
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.
PMID 19509382·JAMA·2009
1-meta
Derivative (1)t(1;19)(p13;p13) in the setting of myelofibrosis with JAK2 V617F.
PMID 19446748·Cancer Genet Cytogenet·2009
5-case
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.
PMID 19287384·Nat Genet·2009
8-other
Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia.
PMID 18316568·Clin Cancer Res·2008
3-trial
Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT).
PMID 17210175·Leuk Res·2007
6-review
The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.
PMID 17123268·Cancer·2007
8-other
Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project.
PMID 16959316·Leuk Res·2007
4-observational
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
PMID 16834459·PLoS Med·2006
7-preclinical
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.
PMID 16868251·Blood·2006
8-other
Determination of the S isotope composition of methanesulfonic acid.
PMID 16841918·Anal Chem·2006
8-other
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).
PMID 16675707·Blood·2006
6-review
X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis.
PMID 16434490·Blood·2006
8-other
The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera.
PMID 16369984·Cancer·2006
8-other
The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates.
PMID 16225651·Br J Haematol·2005
8-other
JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance.
PMID 16197451·Br J Haematol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST, DANA 1B25
BOSTON, MA 02115 - Phone
- (617) 632-6685
Quick Facts
- NPI
- 1972578185
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile